These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6600444)

  • 21. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct pattern of antibody reactivity with oligomeric or polymeric forms of the capsular polysaccharide of Haemophilus influenzae type b.
    Pillai S; Ciciriello S; Koster M; Eby R
    Infect Immun; 1991 Dec; 59(12):4371-6. PubMed ID: 1718875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity in weanling rabbits of a polyribophosphate complex from Haemophilus influenzae type b.
    Anderson P; Smith DH
    J Infect Dis; 1977 Aug; 136 Suppl():S63-70. PubMed ID: 302292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.
    Granoff DM; McHugh YE; Raff HV; Mokatrin AS; Van Nest GA
    Infect Immun; 1997 May; 65(5):1710-5. PubMed ID: 9125551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic peptide representing a T-cell epitope of CRM197 substitutes as carrier molecule in a Haemophilus influenzae type B (Hib) conjugate vaccine.
    Bixler GS; Eby R; Dermody KM; Woods RM; Seid RC; Pillai S
    Adv Exp Med Biol; 1989; 251():175-80. PubMed ID: 2481959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD; Band E; Froeschle JE; McVerry PH
    Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
    Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
    J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
    Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
    Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective antibody deficiency to Haemophilus influenzae type B capsular polysaccharide vaccination in children with recurrent respiratory tract infection.
    Herrod HG; Gross S; Insel R
    J Clin Immunol; 1989 Sep; 9(5):429-34. PubMed ID: 2621246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
    Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
    [No Abstract]   [Full Text] [Related]  

  • 33. The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b.
    Hetherington SV
    J Immunol; 1988 Jun; 140(11):3966-70. PubMed ID: 3259602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological activity of Hib conjugates.
    Vella PP; Staub JM; Ellis RW
    Vaccine; 1991 Jun; 9 Suppl():S26-9; discussion S42-3. PubMed ID: 1891953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
    Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
    N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.
    Fernández-Santana V; Cardoso F; Rodriguez A; Carmenate T; Peña L; Valdés Y; Hardy E; Mawas F; Heynngnezz L; Rodríguez MC; Figueroa I; Chang J; Toledo ME; Musacchio A; Hernández I; Izquierdo M; Cosme K; Roy R; Verez-Bencomo V
    Infect Immun; 2004 Dec; 72(12):7115-23. PubMed ID: 15557635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
    Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
    J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines.
    Daum RS; Hogerman D; Rennels MB; Bewley K; Malinoski F; Rothstein E; Reisinger K; Block S; Keyserling H; Steinhoff M
    J Infect Dis; 1997 Aug; 176(2):445-55. PubMed ID: 9237711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates.
    Lucas AH; Granoff DM
    J Immunol; 1995 Apr; 154(8):4195-202. PubMed ID: 7706754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.